South African vaccine manufacturer Biovac has secured a further $20m (R327m) from two French development finance institutions. This brings its total fundraising to $128m (R2.4bn) and leaves the company within striking distance of its $180m (R2.95bn) target. Moreover, this new investment marks a significant milestone in the ongoing Biovac expansion fundraising effort. Agence Française de Développement and its private-sector arm,…
Tag: Infectious Disease
-
Mpox Global Emergency Downgraded by World Health Officials
The World Health Organisation (WHO) has announced that mpox is no longer a public health emergency of international concern, its highest level of alert. The decision comes after a significant and sustained fall in infection rates in key African nations. WHO Director-General, Dr Tedros Adhanom Ghebreyesus, confirmed the downgrade. The organisation’s Emergency Committee recommended it. The World Health Organisation (WHO)…
-
TB Deaths in South Africa Persist Despite Drop in Infections
Tuberculosis (TB) remains South Africa’s most lethal infectious disease. TB deaths claimed an estimated 56,000 lives in 2023. This occurred even as the number of new infections saw a sharp decline, health officials have revealed. The stark figures highlight a growing paradox in the country’s fight against the disease. Although fewer people are contracting TB, a stubbornly high number are…
-
56,000 South Africans succumbed to tuberculosis in 2023
An estimated 1.25 million people worldwide and 56,000 in South Africa succumbed to tuberculosis (TB) in 2023, according to recent WHO figures. These alarming statistics place TB above COVID-19 as the leading infectious disease killer globally. Marcus Low analyzes these findings, examining TB’s persistent toll in South Africa and the WHO’s goals to reduce both TB incidence and mortality. TB…